"The cell relies on that pathway to survive," he said, explaining that the compound is a likely candidate for drug therapy. "This is the first time VLCAD has been identified as a target in any cancer."
In the first study to look at specific risk indicators for cardiovascular disease (CVD) in young, healthy cannabis users, researchers found subtle but potentially important changes in heart and artery function.
